Side-by-side evidence reviews of the most-discussed peptide pairings. Each comparison ends with a clear verdict — without false equivalence.
Two of the most-discussed peptides in UK weight management. Here's where each one sits on the evidence — without the marketing.
Read comparison Stack components comparedTwo compounds frequently sold together as a "GH stack". They are mechanistically distinct — and most clinical literature treats them as complementary rather than competing.
Read comparison Next-generation comparisonTirzepatide is the current best-evidenced obesity drug. Retatrutide is the most-discussed challenger. Phase-3 retatrutide data hasn't published yet — so this comparison is partial.
Read comparison